Subscribe to Newsletter

Diabetes

Subspecialties Retina

Wide Field, Deep Learning

| Pr. Eric Souied | 5 min read

How AI-assisted UWF imaging is being used to classify retinal vascular diseases

Subspecialties Retina

Eye Sp.Eye Innovation

| Jon Greenaway | 6 min read

How the Sp.Eye system makes intravitreal more efficient for doctors and safer and less stressful for patients

Subspecialties Retina

DR Snapshot

| Sarah Healey | 2 min read

Diabetic retinopathy poses a large global threat to patients and the economy

Subspecialties Diabetes

The Sweet Spot

| Akrit Sodhi | 5 min read

The links between low blood sugar and diabetic eye disease

Business & Profession Retina

Lowering Lipids – and AMD

| Sarah Healey | 2 min read

Systemic lipid-lowering and antidiabetic medications have been found to lower AMD prevalence

Business & Profession Business and Innovation

In Agreement

| Sponsored by PolyPhotonix

PolyPhotonix names Prevail Partners as its lead US investor whose affiliate will lead Noctura 400 FDA clinical trials

Business & Profession Professional Development

One in a Million

| Aleksandra Jones

Sitting Down With… Gladys Atto, ophthalmologist at Moroto Regional Referral Hospital, Moroto, Uganda

Subspecialties Comprehensive

Under Lock and Key

| Wei Yan Ng, Daniel Shu Wei Ting

Improving artificial intelligence development using blockchain – where digital health technologies converge

Subspecialties Retina

Pascal Synthesis Photocoagulator

| Sponsored by Iridex

The fourth iteration of Pascal Laser continues to set the standard in pattern-scanning lasers

Subspecialties Retina

Saving Sight With Light

| Sponsored by PolyPhotonix

Noctura 400 from PolyPhotonix offers a revolutionary, home-based non-invasive diabetic retinopathy treatment that reduces oxygen demand in the retina

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: